Benoît Pilmis
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 31
-
- Antifungal resistance and susceptibility 13
- Co-authors
- Alban Le Monnier (47 shared papers)Jean‐Ralph Zahar (25 shared papers)Olivier Lortholary (23 shared papers)Assaf Mizrahi (39 shared papers)Fanny Lanternier (10 shared papers)Vincent Jullien (6 shared papers)Marc Lecuit (6 shared papers)Caroline M. Charlier (6 shared papers)
In The Last Decade
Benoît Pilmis
122 papers receiving 2.8k citations
Benoît Pilmis's Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Medicine 367
- Applied Microbiology and Biotechnology 116
- Infectious Diseases 848
- Biotechnology 281
- Clinical Biochemistry 190
Countries citing papers authored by Benoît Pilmis
This map shows the geographic impact of Benoît Pilmis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Pilmis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Pilmis more than expected).
Fields of papers citing papers by Benoît Pilmis
This network shows the impact of papers produced by Benoît Pilmis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Pilmis. The network helps show where Benoît Pilmis may publish in the future.
Co-authors
The 25 scholars most cited alongside Benoît Pilmis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 391 |
| 2 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 289 |
| 3 | 2021 | 253 | |
| 4 | 2017 | 159 | |
| 5 | 2014 | 108 | |
| 6 | 2020 | 87 | |
| 7 | 2015 | 66 | |
| 8 | 2018 | 61 | |
| 9 | 2016 | 56 | |
| 10 | 2017 | 55 | |
| 11 | 2017 | 54 | |
| 12 | 2019 | 53 | |
| 13 | 2017 | 49 | |
| 14 | 2019 | 44 | |
| 15 | 2018 | 42 | |
| 16 | 2015 | 40 | |
| 17 | 2019 | 39 | |
| 18 | 2017 | 37 | |
| 19 | 2015 | 32 | |
| 20 | 2014 | 31 |
About Benoît Pilmis
Benoît Pilmis is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 131 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (31 papers), Bacterial Identification and Susceptibility Testing (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Antifungal resistance and susceptibility (13 papers), Antibiotic Use and Resistance (12 papers), Pneumonia and Respiratory Infections (10 papers), Infective Endocarditis Diagnosis and Management (10 papers) and Fungal Infections and Studies (9 papers). The work is most often cited by research in Molecular Medicine (367 citations), Applied Microbiology and Biotechnology (116 citations), Infectious Diseases (848 citations), Biotechnology (281 citations) and Clinical Biochemistry (190 citations). Benoît Pilmis has collaborated with scholars based in France, Lebanon and Spain. Frequent co-authors include Alban Le Monnier, Jean‐Ralph Zahar, Olivier Lortholary, Assaf Mizrahi, Fanny Lanternier, Vincent Jullien, Marc Lecuit, Caroline M. Charlier, O. Lortholary and J.-R. Zahar. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Antibiotics and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.